serorex 20 mg filmovertrukne tabletter
scandpharm generics ab - paroxetin - filmovertrukne tabletter - 20 mg
serorex 30 mg filmovertrukne tabletter
scandpharm generics ab - paroxetinhydrochlorid anhydrat - filmovertrukne tabletter - 30 mg
dapson "scanpharm" 50 mg tabletter
scanpharm a/s - dapson - tabletter - 50 mg
menadion "scanpharm" 10 mg tabletter
scanpharm a/s - phytomenadion - tabletter - 10 mg
paracetamol "scanpharm" 1000 mg suppositorier
scanpharm a/s - paracetamol - suppositorier - 1000 mg
dapson "scanpharm" 100 mg tabletter
scanpharm a/s - dapson - tabletter - 100 mg
paracetamol "scanpharm" 125 mg suppositorier
scanpharm a/s - paracetamol - suppositorier - 125 mg
clopidogrel teva generics b.v.
teva pharma b.v. - clopidogrel (as hydrochloride) - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotiske midler - clopidogrel er indiceret hos voksne til forebyggelse af atherothrombotic begivenheder i:patienter med myokardieinfarkt (fra få dage, indtil der er mindre end 35 dage), iskæmisk slagtilfælde (fra 7 dage indtil mindre end 6 måneder) eller etableret perifer arteriel sygdom. patients suffering from acute coronary syndrome:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st-segment elevation akut myokardieinfarkt, i kombination med asa i medicinsk behandlede patienter, der er berettiget til trombolytisk terapi. for yderligere oplysninger henvises der til afsnit 5.
saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, systemisk - immunosuppressiva - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.
mega c 1500 "scanpharm" 1500 mg depottabletter
scanpharm a/s - ascorbinsyre - depottabletter - 1500 mg